35 filings
Page 2 of 2
8-K
m57vdsji
27 May 22
Submission of Matters to a Vote of Security Holders
5:24pm
8-K
r3ya8zbdncbraau
12 May 22
4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates
4:32pm
8-K
h3gkj
28 Mar 22
4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights
4:38pm
8-K
bzs9jr21
22 Feb 22
Departure of Directors or Certain Officers
4:45pm
8-K
3fis11876
11 Jan 22
Regulation FD Disclosure
7:01am
8-K
gnzj5a8qy3h 3r
10 Nov 21
4D Molecular Therapeutics Reports Financial Results for the Third Quarter of 2021 and Provides Operational Highlights
4:20pm
8-K
6forcxhe34dm lv
26 Oct 21
Other Events
6:30am
8-K
ybxoubv8xxuql
13 Oct 21
Other Events
4:37pm
8-K
kthlmb
24 Sep 21
Departure of Directors or Certain Officers
4:59pm
8-K
xsu1qh
12 Aug 21
4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights
4:16pm
8-K
mbxtq0io1kctbzwrasb0
25 Jun 21
Termination of a Material Definitive Agreement
4:01pm
8-K
732 mfxg7b2
20 May 21
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
3s70he
13 May 21
4D Molecular Therapeutics Reports Financial Results for the First Quarter of 2021 and Provides Operational Highlights
4:15pm
8-K
1gyu85j
25 Mar 21
Results of Operations and Financial Condition
4:11pm
8-K
7gqtr hxar
15 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:01pm